Cytomed Therapeutics LTD (GDTC) SEC Filings — 2025

Filings

• CytoMed Therapeutics to Explore Phase I Trial with Universiti Malaya — 6-K · Dec 8, 2025
• CytoMed Acquires TC BioPharm Assets for Cancer Treatment — 6-K · Nov 18, 2025
• Cytomed Therapeutics LTD 6-K Filing — 6-K · Nov 6, 2025
• CytoMed Chairman Buys More Shares — 6-K · Oct 22, 2025
• CytoMed Therapeutics Bids for TC BioPharm Assets — 6-K · Oct 14, 2025
• CytoMed Therapeutics AML Research Published — 6-K · Oct 2, 2025
• CytoMed Therapeutics Files 6-K for Period Ending 06/30/2025 — 6-K · Sep 30, 2025
• CytoMed Expands NK Cell Production, Plans New Cord Blood Biotech — 6-K · Aug 28, 2025
• CytoMed Therapeutics Signs At-the-Market Sales Agreement — 6-K · Aug 19, 2025
• CytoMed Therapeutics Issues Press Release — 6-K · Jul 21, 2025
• CytoMed Therapeutics Holds Annual Shareholders Meeting — 6-K · Jul 3, 2025
• CytoMed Therapeutics Files 6-K for Annual Shareholder Meeting — 6-K · May 16, 2025
• CytoMed Therapeutics Ltd Files 20-F for FY2024 — 20-F · Apr 28, 2025
• CytoMed Therapeutics Ltd. Files January 2025 6-K Report — 6-K · Jan 6, 2025